Quality of life in patients with localized prostate cancer

被引：22

作者：

Quek, ML ^{[1
]}

Penson, DF ^{[1
]}

机构：

[1] Univ So Calif, Keck Sch Med, Dept Urol, Los Angeles, CA 90089 USA

来源：

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2005年 / 23卷 / 03期

关键词：

prostate cancer; quality of life; impotence; incontinence;

D O I：

10.1016/j.urolonc.2005.03.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

To date, there are no studies conclusively documenting that one treatment for localized prostate cancer is superior to another in terms of overall survival. Therefore, patients must consider other outcomes when choosing primary therapy for localized disease. One of the most important factors patients consider when choosing their treatment is the effect of therapy on their quality of life (QOL). Over the past decade, there have been an increasing number of studies assessing health related QOL (HRQOL) outcomes in localized prostate cancer. The goal of this article is to review Our current understanding of HRQOL in this disease. We will begin by examining the established HRQOL instruments for use in localized prostate cancer. We will then discuss the effect of various treatments on QOL and review the literature comparing HRQOL outcomes between therapies. (c) 2005 Elsevier Inc. All rights reserved.

引用

页码：208 / 215

页数：8

共 69 条

[1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].

AARONSON, NK ;

AHMEDZAI, S ;

BERGMAN, B ;

BULLINGER, M ;

CULL, A ;

DUEZ, NJ ;

FILIBERTI, A ;

FLECHTNER, H ;

FLEISHMAN, SB ;

DEHAES, JCJM ;

KAASA, S ;

KLEE, M ;

OSOBA, D ;

RAZAVI, D ;

ROFE, PB ;

SCHRAUB, S ;

SNEEUW, K ;

SULLIVAN, M ;

TAKEDA, F .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376

[2]

AARONSON NK, 2001, EORTC PROTOCOL 15011

[3] Long-term results of a randomized trial for the treatment of Stages B2 and C prostate cancer: Radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities [J].

Akakura, K ;

Isaka, S ;

Akimoto, S ;

Ito, H ;

Okada, K ;

Hachiya, T ;

Yoshida, O ;

Arai, Y ;

Usami, M ;

Kotake, T ;

Tobisu, K ;

Ohashi, Y ;

Sumiyoshi, Y ;

Kakizoe, T ;

Shimazaki, J .

UROLOGY, 1999, 54 (02) :313-318

[4] Health-related quality of life among patients with metastatic prostate cancer [J].

Albertsen, PC ;

Aaronson, NK ;

Muller, MJ ;

Keller, SD ;

Ware, JE .

UROLOGY, 1997, 49 (02) :207-216

[5] Watchful waiting and health related quality of life for patients with localized prostate cancer: Data from CaPSURE [J].

Arredondo, SA ;

Downs, TM ;

Lubeck, DP ;

Pasta, DJ ;

Silva, SJ ;

Wallace, KL ;

Carroll, PR .

JOURNAL OF UROLOGY, 2004, 172 (05) :1830-1834

[6]

Arterbery VE, 1997, SEMIN SURG ONCOL, V13, P461, DOI 10.1002/(SICI)1098-2388(199711/12)13:6<461::AID-SSU11>3.0.CO

[7]

2-W

[8] The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients [J].

Bacon, CG ;

Giovannucci, E ;

Testa, M ;

Glass, TA ;

Kawachi, I .

CANCER, 2002, 94 (03) :862-871

[9] The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer [J].

Bacon, CG ;

Giovannucci, E ;

Testa, M ;

Kawachi, I .

JOURNAL OF UROLOGY, 2001, 166 (05) :1804-1810

[10] Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30 [J].

Borghede, G ;

Sullivan, M .

QUALITY OF LIFE RESEARCH, 1996, 5 (02) :212-222

← 1 2 3 4 5 6 7 →